Status:
UNKNOWN
The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Polycystic Kidney Diseases
Polycystic Liver Disease
Eligibility:
All Genders
20+ years
Brief Summary
Primary sarcopenia is used to describe aging and progressed with the physiologic decline. Secondary sarcopenia is associated many chronic disease, including acquired immune deficiency syndrome, cancer...
Detailed Description
The imaging study (CT or MRI) will be performed within one month before the procedure to measure total kidney volume and psoas muscle area. The procedure will use transcatheter embolization to renal ...
Eligibility Criteria
Inclusion
- Polycystic related disease with medical images (CT or MRI) diagnosed
- Aged over 20 years
Exclusion
- Lack of Bio-exam or medical images
- Pregnancy
Key Trial Info
Start Date :
September 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05215964
Start Date
September 29 2020
End Date
December 31 2023
Last Update
January 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NTUH
Taipei, Taiwan, 100226